MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

    O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

    Objective: The aim of this study was to investigate effects of dophaminergic therapy on olfaction of patients with Parkinson's disease. Background: Influence of dopaminergic drugs…
  • 2016 International Congress

    Clinical features of Parkinson’s disease patients developing stridor with acute respiratory failure

    J. Tashiro, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

    Objective: To clarify the clinical features of Parkinson's disease patients who developed stridor with acute respiratory failure due to vocal cord paralysis or laryngeal dystonia.…
  • 2016 International Congress

    An innovative international educational network to improve physicians’ current management practices of patients with cervical dystonia and spasticity

    C. Colosimo, K. Bhatia, R. Bhidayasiri, T.M. Chung, L.J. Jacinto, T. Landreau, K. Fheodoroff (Terni, Italy)

    Objective: The Ixcellence Network® aims to improve patient care in the fields of cervical dystonia (CD) and spasticity through the development of a high level…
  • 2016 International Congress

    Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

    A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)

    Objective: To report the statistical analyses exploring the association between BMI and change in Unified Parkinson's disease Rating Scale (UPDRS) scores and survival in the…
  • 2016 International Congress

    Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population

    G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge de Saráchaga, M. Escobar-Barrios, E. Carreón-Bautista (Mexico City, Mexico)

    Objective: To determine the role of cardiometabolic syndrome such as type 2 diabetes mellitus, hypertension, obesity, dyslipidemia and the risk of developing Parkinson's disease. Background:…
  • 2016 International Congress

    The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

    V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)

    Objective: To investigate whether the predominant initial PD motor symptom is associated with gender or age of onset of PD in Sri Lanka. Background: Studies…
  • 2016 International Congress

    Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients

    S.E. Oyler, J.E. Fleisher, M.M. Sweeney, A.C. Lemen, A. Fazl, G. Dacpano, R.M. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)

    Objective: To examine the number and types of medication errors detected by a registered nurse during interdisciplinary home visits for patients with advanced Parkinson's disease…
  • 2016 International Congress

    Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease

    M.A. Higuchi, T. Mishima, H. Abe, T. Morishita, S. Fujioka, J. Fukae, Y. Tsuboi (Fukuoka, Japan)

    Objective: To evaluate the influence of pretreatment subclinical apathy on patient QOL following subthalamic nucleus DBS (STN-DBS) in PD patients 12 months after surgery. Background:…
  • 2016 International Congress

    Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease

    C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…
  • 2016 International Congress

    Measuring interdependence of the health status of people with Parkinson’s disease and their spouses

    F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)

    Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley